Anti-coagulants

ACP Journals: Annals of Internal Medicine: Published on November, 2022Current guidelines recommend using direct oral anticoagulants (DOACs) over warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to guide the choice of DOAC.The aim of the study is to do a large-scale comparison between all DOACs (apix...
A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).For patients with COVID-19 who are being discharged from the hospital and who do not have suspected or confirmed venous thromboembolism or another indication for anticoagulation, the ASH guide...
A study published Oct. 12 in the Annals of Internal Medicine that compared three types of direct oral anticoagulants (DOACs) found that rivaroxaban was associated with a much higher risk of overall and major gastrointestinal bleeding than apixaban or dabigatran, according to a study. Other studies yield similar results.The researchers found th...
In patients with severe or critical Coronavirus disease 2019 (COVID-19) manifestations, a thromboinflammatory syndrome, with diffuse microvascular thrombosis, is increasingly evident as the final step of pro-inflammatory cytokines storm. Actually, no proven effective therapies for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) i...